Analyst Ratings for Eli Lilly (LLY)

Overall Rating: NEUTRAL Rating Trend: Down

Avg. $ Target: $48.14 (-13.9%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
1/17/2013	CLSA	New Coverage	Sell (N/A)	47.00 (N/A)	52.93	55.90	5.61%	Details
11/30/2012	Citi	New Coverage	Buy (N/A)	55.00 (N/A)	48.58	55.90	15.07%	Details
10/15/2012	Leerink Swann	Upgrade	Outperform (Market Perform)	59.50 (52.00)	50.45	55.90	10.8%	Details
10/12/2012	Cowen	Downgrade	Underperform (Neutral)	N/A (N/A)	50.60	55.90	10.47%	Details
10/9/2012	Goldman Sachs » Updated 4/24/2013	Upgrade	Neutral (Sell)	56.00 (N/A)	50.78	55.90	10.08%	Details
9/5/2012	Bernstein	Upgrade	Outperform (Market Perform)	52.00 (46.00)	45.29	55.90	23.43%	Details
8/28/2012	Atlantic Equities	Upgrade	Overweight (Underweight)	N/A (N/A)	44.59	55.90	25.36%	Details
8/24/2012	Credit Suisse	Upgrade	Outperform (Neutral)	N/A (N/A)	42.40	55.90	31.84%	Details
7/30/2012	Jefferies » Updated 4/10/2013	Downgrade	Underperform (Hold)	44.00 (43.00)	44.37	55.90	25.99%	Details
5/18/2012	BMO Capital	New Coverage	Market Perform (N/A)	37.00 (N/A)	40.53	55.90	37.92%	Details
3/2/2012	JPMorgan	Upgrade	Neutral (N/A)	40.00 (N/A)	39.35	55.90	42.06%	Details
2/14/2012	ISI Group	New Coverage	Neutral (N/A)	N/A (N/A)	38.85	55.90	43.89%	Details
12/20/2011	MKM Partners » Updated 10/9/2012	New Coverage	Sell (N/A)	49.00 (44.00)	40.74	55.90	37.21%	Details
10/28/2011	First Global	Upgrade	Moderate Outperform (N/A)	N/A (N/A)	37.87	55.90	47.61%	Details
8/10/2011	Argus	Upgrade	Buy (N/A)	N/A (N/A)	35.64	55.90	56.85%	Details

Like LLY Ratings? Also take a look at BMY, PFE, MRK, NVO